BIOMAT Database Logo BIOMAT Database Logo

Hexahydropyrimidines. VI. Some 2-[4-[N,N-Bis (2-chloroethyl)amino]aryl]-1,3-bis(aralkyl)hexahydropyrimidines. 1965

J H Billman, and J L Meisenheimer

UI MeSH Term Description Entries
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D002279 Carcinoma 256, Walker A transplantable carcinoma of the rat that originally appeared spontaneously in the mammary gland of a pregnant albino rat, and which now resembles a carcinoma in young transplants and a sarcoma in older transplants. (Stedman, 25th ed) Carcinosarcoma 256, Walker,Walker Carcinoma 256,Walker Carcinosarcoma 256
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000963 Antimetabolites Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033) Antimetabolite

Related Publications

J H Billman, and J L Meisenheimer
Hexahydropyrimidines. 8. Synthesis of 2-substituted 1,3-bis(4-[N,N-bis(2-chloroethyl)amino]BENZYL)hexahydropyrimidines as transport molecules for tumor inhibition.
March 1968, Journal of medicinal chemistry,
J H Billman, and J L Meisenheimer
Hexahydropyrimidines IX. Synthesis of 2-substituted-1,3-bis[2-methyl-4-[N,N-bis(2-chloroethyl)-amino]benzyl]hexahydropyrimidines as transport molecules for tumor inhibition.
October 1968, Journal of pharmaceutical sciences,
J H Billman, and J L Meisenheimer
Hexahydropyrimidines. VII. A study of 2-substituted 1,3-bis(2-hydroxy-3-methoxybenzyl)hexahydropyrimidines and 2-substituted 1,3-bis(3,4-dimethoxybenzyl)hexahydropyrimidines as antitumor agents.
May 1966, Journal of medicinal chemistry,
J H Billman, and J L Meisenheimer
Hexahydropyrimidines. L. Preparation of 2-substituted-1,3-bis(p-dimethylamino-benzyl)-hexahydropyrimidines.
November 1962, Journal of pharmaceutical sciences,
J H Billman, and J L Meisenheimer
Potential antitumor agent dicyclohexylammonium 2-(4-N,N-bis(2-chloroethyl) amino)phenoxy)-2-methylpropionate.
April 1972, Journal of medicinal chemistry,
J H Billman, and J L Meisenheimer
Hexahydropyrimidines. V. A study of 2-substituted 1,3-bis(alpha-cyanobenzyl)-hexahydropyrimidines and 2-substituted 1,3-bis(alpha-cyano-p-methoxybenzyl)-hexahydropyrimidines as prospective antitumor agents.
July 1965, Journal of medicinal chemistry,
J H Billman, and J L Meisenheimer
Local anaesthetic activity of some sec-amino-N-(aryl-aralkyl)-ethyl acetamides.
January 1978, Indian journal of physiology and pharmacology,
J H Billman, and J L Meisenheimer
Discovery of N-(2-Amino-4-Fluorophenyl)-4-[bis-(2-Chloroethyl)-Amino]-Benzamide as a Potent HDAC3 Inhibitor.
January 2020, Frontiers in oncology,
J H Billman, and J L Meisenheimer
[Partially hydrogenated N-aryl- and N-aralkyl-derivatives of 1-(2-aminoethyl)-piperidine. VI..].
January 1954, Il Farmaco; edizione scientifica,
J H Billman, and J L Meisenheimer
Synthesis of some new 2-[4-(2-furoyl)-1-piperazinyl]-N-aryl/aralkyl acetamides as potent antibacterial agents.
May 2018, Pakistan journal of pharmaceutical sciences,
Copied contents to your clipboard!